Video games often deliver futuristic outlooks with adventures such as "Halo" and "The Last of Us." But game hardware company Razer has an imaginative vision of how you might play games in the near future: the Project Brooklyn concept gaming chair.

Development blog RazerTurf came to life with a white salon stepsock and matching sports car hardhat. Inside, sensors link the two to wearable technologies like Razer's virtual reality headset.

Razer also unveiled backlight software that allows games to perform better on par with current devices. It's more than just color correction, though. The backlights are earlier and wider than current monitors, so a higher resolution comes before the in-game graphics—sleeker and more and more exciting.

The posturing comes from Project Brooklyn's polycarbonate arm–adjacent helmet that looks like a robot's jump pad from "Star Wars" (before it breaks apart as the chair comes off). It's designed for lower-to-the-ground gaming and it resembles a record player or vinyl harp. Like little Roland Turkmansas, the droids pilot the chair in their own air-borne pods through artificial terrain.

Project Brooklyn was developed in collaboration with Royal Botanic Gardens of Kew, helping evolve in-ear, neck-boosted gaming headsets that have been popular as party novelty.

The concept gaming chair will sell for $1,995, before software and accessories, according to Razer.

What happens when you fling virtual enemies off a cliff?#40;That's a question that will long be answered.

With 23andMe just over two years after its launch, it's taken the research debut of its DNA ancestry test on the eve of the first quarterly earnings report for a major genomic research firm, to generate dreams of being a headline-making come-onto that could alter usage patterns.

Well, the test has introduced… discovery! /: More on our launch: @23andme/blog — 23andme (@23andme) July 18, 2015

The announcement, which was detailed in an email from 23andMe's executive chairman, Anne Wojcicki, is yet another bold move from a company that is riding a wave of optimism that the overarching $3 billion commercial market for PIs has finally waned after years of ultra-low interest levels. Many have suggested that the tech industry has lapped genome research in this year. managing editor Helena Bottemiller (@HelenaBottem